Learn More
Cayman Chemical Fluorescent BrIghtenr 28 5g

Supplier: Cayman Chemical 419955 G

A neutral lipid has been used in the generation of LNPs intravenous administration of LNPs containing DNCA and encapsulating siRNA targeting BRAFV600E reduce tumor BRAFV600E expression and tumor weight and volume without reducing animal weight in an A375 melanoma mouse xenograft model intratumoral administration of LNPs containing DNCA and encapsulating cyclic di-GMP decreases tumor volume increase survival and increase the ratio of tumor-associated cytotoxic/exhausted CD4 and CD8 T cells in an EO771 murine model of primary breast cancer with tumor rechallenge
The Fisher Scientific Encompass Program offers items which are not part of our distribution portfolio. These products typically do not have pictures or detailed descriptions. However, we are committed to improving your shopping experience. Please use the form below to provide feedback related to the content on this product.